Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jun 29, 2010

Premium

Alan Sherr has become vice president and chief intellectual property counsel for RainDance Technologies. He joins the company from Helicos BioSciences, where he was also vice president and chief intellectual property counsel. Before that, he was senior IP counsel and vice president of licensing at Affymetrix. Sherr holds a JD from Boston University, an MSEE from Stanford University, and a BSEE from Rensselaer Polytechnic Institute.


Febit's CEO and president, Cord Stähler, has resigned and joined Siemens Healthcare. He has been replaced by Hartmut Voss, who is co-CEO of the company along with Jochen Kohlhaas, Febit's chief financial officer. Voss joined the company as part of a restructuring of the company to exit the sequencing business and focus on miRNA biomarker discovery (see story, this issue).

Voss co-founded Lion Bioscience, and he also serves as an advisor at Dievini Hopp BioTech Holding and chief business officer at Life Biosystems.


Sandeep Nayyar has joined Power Integrations as the company's chief financial officer, leaving Applied Biosystems where he served as vice president of finance.

Previously, Nayyar was at Quantum Corporation, where he held multiple financial roles, including vice president of finance.


NABsys, which is developing an electronic, solid-state, single-molecule DNA sequencing platform, has appointed Leroy Hood to its board of directors. Hood is the co-founder and president of the Institute for Systems Biology, and has helped launch companies such as Amgen and Applied Biosystems.


The Ontario Genomics Institute has appointed Alison Symington as vice president of outreach. She will be responsible for OGI's external stakeholder relations, corporate communications, and educational outreach programs.

Symington joins OGI from Bioscience Education Canada where she served as executive director. She was also a professor at Seneca College, and holds a PhD in cell biology from the University of Toronto.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.